These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28229294)

  • 1. Perioperative complications and safety of type II thyroplasty (TPII) for adductor spasmodic dysphonia.
    Mizoguchi K; Hatakeyama H; Yanagida S; Nishizawa N; Oridate N; Fukuda S; Homma A
    Eur Arch Otorhinolaryngol; 2017 May; 274(5):2215-2223. PubMed ID: 28229294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Comparison of Thyroarytenoid Muscle Myectomy and Type II Thyroplasty for Spasmodic Dysphonia.
    Nomoto M; Tokashiki R; Hiramatsu H; Konomi U; Motohashi R; Sakurai E; Toyomura F; Ueda Y; Inoue S; Tsukahara K; Suzuki M
    J Voice; 2015 Jul; 29(4):501-6. PubMed ID: 25737474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term Evaluation of Type 2 Thyroplasty with Titanium Bridges for Adductor Spasmodic Dysphonia.
    Sanuki T; Yumoto E
    Otolaryngol Head Neck Surg; 2017 Jul; 157(1):80-84. PubMed ID: 28463639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term voice handicap index after type II thyroplasty using titanium bridges for adductor spasmodic dysphonia.
    Sanuki T; Yumoto E; Kodama N; Minoda R; Kumai Y
    Auris Nasus Larynx; 2014 Jun; 41(3):285-9. PubMed ID: 24369905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Voice tuning with new instruments for type II thyroplasty in the treatment of adductor spasmodic dysphonia.
    Sanuki T; Yumoto E; Toya Y; Kumai Y
    Auris Nasus Larynx; 2016 Oct; 43(5):537-40. PubMed ID: 26811303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of type II thyroplasty on adductor spasmodic dysphonia.
    Sanuki T; Yumoto E; Minoda R; Kodama N
    Otolaryngol Head Neck Surg; 2010 Apr; 142(4):540-6. PubMed ID: 20304275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of type II thyroplasty for adductor spasmodic dysphonia: analysis of revision and unsatisfactory cases.
    Sanuki T; Isshiki N
    Acta Otolaryngol; 2009 Nov; 129(11):1287-93. PubMed ID: 19863326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Operative Procedure of Anterior Commissure for Type II Thyroplasty.
    Matsushima K; Isshiki N; Tanabe M; Yoshizaki N; Otsu K; Fukuo A; Matsuura K; Watanabe Y; Sato K
    J Voice; 2018 May; 32(3):374-380. PubMed ID: 28687381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bilateral Vocal Fold Medialization: A Treatment for Abductor Spasmodic Dysphonia.
    Dewan K; Berke GS
    J Voice; 2019 Jan; 33(1):45-48. PubMed ID: 29132808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Durability of Titanium Implants Following Type II Thyroplasty for Adductor Type Spasmodic Dysphonia.
    Toya Y; Hiroshiba S
    Laryngoscope; 2023 Nov; 133(11):3028-3033. PubMed ID: 37070643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid-type Botulinum Toxin Type A in Adductor Spasmodic Dysphonia: A Prospective Pilot Study.
    Cha W; Jang JY; Wang SG; Kang JH; Jo MG
    J Voice; 2017 May; 31(3):378.e19-378.e24. PubMed ID: 27520509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symptomatic unilateral vocal fold paralysis following cardiothoracic surgery.
    Puccinelli C; Modzeski MC; Orbelo D; Ekbom DC
    Am J Otolaryngol; 2018; 39(2):175-179. PubMed ID: 29254704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type I gore-tex laryngoplasty for glottic incompetence in mobile vocal folds.
    Buckmire RA; Bryson PC; Patel MR
    J Voice; 2011 May; 25(3):288-92. PubMed ID: 20236795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of Outpatient Type 1 Thyroplasty.
    Patel J; Boon M; Spiegel J; Huntley C
    Ear Nose Throat J; 2021 Sep; 100(5_suppl):608S-613S. PubMed ID: 31903781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type I Thyroplasty After Arytenoidectomy and Posterior Cordectomy.
    Valentino W; Paknezhad H; Sataloff RT
    Ear Nose Throat J; 2020 Aug; 99(7):NP75-NP76. PubMed ID: 31111728
    [No Abstract]   [Full Text] [Related]  

  • 16. Arytenoid adduction with nerve-muscle pedicle transfer vs arytenoid adduction with and without type I thyroplasty in paralytic dysphonia.
    Hassan MM; Yumoto E; Sanuki T; Kumai Y; Kodama N; Baraka MA; Wahba H; Hafez NG; El-Adawy AA
    JAMA Otolaryngol Head Neck Surg; 2014 Sep; 140(9):833-9. PubMed ID: 25123168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type II thyroplasty changes cortical activation in patients with spasmodic dysphonia.
    Tateya I; Omori K; Kojima H; Naito Y; Hirano S; Yamashita M; Ito J
    Auris Nasus Larynx; 2015 Apr; 42(2):139-44. PubMed ID: 25199736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of Parkinson's-related dysphonia by thyroplasty.
    Roubeau B; Bruel M; de Crouy Chanel O; Périé S
    Eur Ann Otorhinolaryngol Head Neck Dis; 2016 Dec; 133(6):437-439. PubMed ID: 27522148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroplasty for adductor spasmodic dysphonia: further experiences.
    Isshiki N; Haji T; Yamamoto Y; Mahieu HF
    Laryngoscope; 2001 Apr; 111(4 Pt 1):615-21. PubMed ID: 11359129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Voice and laryngeal configuration of men with unilateral vocal fold paralysis before and after medialization.
    Schwarz K; Cielo CA; Steffen N; Becker J; Jotz GP
    J Voice; 2011 Sep; 25(5):611-8. PubMed ID: 20951549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.